Chad Cowan

CIK: 0002039294

Transaction Breakdown

Open Market Buys (P)1 (10.0%)

High conviction signal

Open Market Sales (S)1 (10.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IPSC

Century Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

IPSC
Century Therapeutics, Inc.
Jun 11, 2026
Tax Payment(F)
Direct
358 shares at avg. $2.24$801.92
IPSC
Century Therapeutics, Inc.
Apr 1, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $2.19$3K
IPSC
Century Therapeutics, Inc.
Mar 11, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $2.73$4K
IPSC
Century Therapeutics, Inc.
Feb 2, 2026
Award(A)
Direct
135K shares-
IPSC
Century Therapeutics, Inc.
Jan 2, 2026
Tax Payment(F)
Direct
1.6K shares at avg. $0.99$2K
IPSC
Century Therapeutics, Inc.
Dec 22, 2025
Purchase(P)
Direct
58.1K shares at avg. $0.85$49K
IPSC
Century Therapeutics, Inc.
Nov 20, 2025
Sale(S)
Direct
5.5K shares at avg. $0.50$3K
IPSC
Century Therapeutics, Inc.
Sep 18, 2025
Award(A)
Direct
762.5K shares-
IPSC
Century Therapeutics, Inc.
Mar 11, 2025
Award(A)
Direct
19.5K shares-
IPSC
Century Therapeutics, Inc.
Oct 1, 2024
Award(A)
Direct
74.4K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	IPSC Century Therapeutics, Inc.	Tax Payment(F)	358	$2.24	$802	Direct
Apr 1, 2026	IPSC Century Therapeutics, Inc.	Tax Payment(F)	1,365	$2.19	$2,989	Direct
Mar 11, 2026	IPSC Century Therapeutics, Inc.	Tax Payment(F)	1,431	$2.73	$3,907	Direct
Feb 2, 2026	IPSC Century Therapeutics, Inc.	Award(A)	135,000	-	$0	Direct
Jan 2, 2026	IPSC Century Therapeutics, Inc.	Tax Payment(F)	1,611	$0.99	$1,603	Direct
Dec 22, 2025	IPSC Century Therapeutics, Inc.	Purchase(P)	58,060	$0.85	$49,252	Direct
Nov 20, 2025	IPSC Century Therapeutics, Inc.	Sale(S)	5,462	$0.50	$2,736	Direct
Sep 18, 2025	IPSC Century Therapeutics, Inc.	Award(A)	762,543	-	-	Direct
Mar 11, 2025	IPSC Century Therapeutics, Inc.	Award(A)	19,500	-	-	Direct
Oct 1, 2024	IPSC Century Therapeutics, Inc.	Award(A)	74,376	-	$0	Direct

1-10 of 10 transactions

About Cowan Chad

Cowan Chad (SEC CIK 0002039294) files insider reports with the SEC as Chief Scientific Officer of Century Therapeutics, Inc. (IPSC).

Signal8 holds 11 ownership filings by Cowan Chad (1 Form 3, 10 Form 4), filed between Oct 3, 2024 and Jun 15, 2026. Those filings report 10 transactions, from Oct 1, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cowan Chad's filings is in PHILADELPHIA, PA.

Recent filings by Cowan Chad

Jun 11, 2026: Tax withholding of IPSC shares (Form 4, code F).
Apr 1, 2026: Tax withholding of IPSC shares (Form 4, code F).
Mar 11, 2026: Tax withholding of IPSC shares (Form 4, code F).
Feb 2, 2026: Grant or award of IPSC shares (Form 4, code A).
Jan 2, 2026: Tax withholding of IPSC shares (Form 4, code F).

Other insiders filing for Century Therapeutics, Inc. (IPSC)

Russotti Gregory
Carr Douglas, SVP Finance & Operations
Pfeiffenberger Brent, President and CEO
Truitt Joseph, Director
Riva Alessandro, Director
Quimi Daphne, Director

How to read Form 4 transaction codes